Immediate Impact
72 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Massimo Cajozzo being referenced
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Massimo Cajozzo | 155 | 142 | 94 | 45 | 394 | |
| Reiko Yamada | 131 | 163 | 97 | 57 | 405 | |
| Ilias Athanasiadis | 161 | 167 | 166 | 35 | 392 | |
| Kotaro Kitani | 125 | 158 | 109 | 45 | 353 | |
| David M. Sella | 215 | 142 | 55 | 36 | 450 | |
| Xiaoli Zhu | 119 | 95 | 76 | 37 | 428 | |
| Sonja Kroep | 159 | 236 | 85 | 32 | 450 | |
| Rima Patel | 59 | 117 | 67 | 36 | 369 | |
| J Clavier | 235 | 63 | 189 | 32 | 458 | |
| Kensuke Fukuda | 158 | 145 | 78 | 43 | 357 | |
| Bedros Taslakian | 91 | 136 | 50 | 51 | 398 |
All Works
Loading papers...